Common Stock, Shares, Issued of Iterum Therapeutics plc from Q3 2015 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Iterum Therapeutics plc quarterly Common Stock, Shares, Issued history and change rate from Q3 2015 to Q3 2025.
  • Iterum Therapeutics plc Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 49M shares, a 116% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Iterum Therapeutics plc Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 49M +26.3M +116% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 42.1M +25.5M +154% 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 35.7M +19.2M +117% 31 Mar 2025 10-Q 13 May 2025
Q4 2024 31.5M +18M +134% 31 Dec 2024 10-Q 14 Nov 2025
Q3 2024 22.7M +9.66M +74.1% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 16.6M +3.56M +27.3% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 16.5M +3.66M +28.6% 31 Mar 2024 10-Q 13 May 2024
Q4 2023 13.5M +900K +7.15% 31 Dec 2023 10-K 07 Feb 2025
Q3 2023 13M +808K +6.6% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 13M -170M -92.9% 30 Jun 2023 10-Q 11 Aug 2023
Q1 2023 12.8M -171M -93% 31 Mar 2023 10-Q 12 May 2023
Q4 2022 12.6M +414K +3.4% 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 12.2M -171M -93.3% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 184M +906K +0.5% 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 183M +4.22M +2.35% 31 Mar 2022 10-Q 13 May 2022
Q4 2021 12.2M -37.2M -75.3% 31 Dec 2021 10-K 16 Mar 2023
Q3 2021 183M +162M +761% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 183M +165M +923% 30 Jun 2021 10-Q 13 Aug 2021
Q1 2021 179M +164M +1105% 31 Mar 2021 10-Q 14 May 2021
Q4 2020 49.4M +34.6M +232% 31 Dec 2020 10-K 28 Mar 2022
Q3 2020 21.2M +6.37M +42.8% 30 Sep 2020 10-Q 16 Nov 2020
Q2 2020 17.9M +3.44M +23.9% 30 Jun 2020 10-Q 06 Aug 2020
Q1 2020 14.9M +502K +3.49% 31 Mar 2020 10-Q 14 May 2020
Q4 2019 14.9M +517K +3.6% 31 Dec 2019 10-K 12 Mar 2021
Q3 2019 14.9M +710K +5.01% 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 14.4M +248K +1.75% 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 14.4M +14M +3378% 31 Mar 2019 10-Q 14 May 2019
Q4 2018 14.4M +13.9M +3374% 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 14.2M 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 14.2M 30 Jun 2018 10-Q 14 Aug 2018
Q1 2018 413K 13 Mar 2018 10-K 28 Mar 2022
Q4 2017 413K 31 Dec 2017 10-K 25 Mar 2019
Q3 2015 413K 14 Oct 2015 10-K 28 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.